John Oyler - 23 Jun 2026 Form 4 Insider Report for BeOne Medicines Ltd. (ONC)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
25 Jun 2026, 17:15:01 UTC
Prior SEC filing
18 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Qing Nian, as Attorney-in-Fact

Key filing fact

John Oyler filed Form 4 for BeOne Medicines Ltd. (ONC) on 25 Jun 2026.

Key facts

  • This page summarizes John Oyler's Form 4 filing for BeOne Medicines Ltd. (ONC).
  • 3 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 25 Jun 2026, 17:15.

Change

  • Previous filing in this sequence was filed on 18 Jun 2026.
  • Current net transaction value: -$933,592.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001042047 Primary reporting owner

OYLER JOHN

Relationship
Chief Executive Officer, Director
Address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, SWITZERLAND
Signature
/s/ Qing Nian, as Attorney-in-Fact
Signature date
25 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ONC transaction

American Depositary Shares

Sale

Transaction value
$491,949
Shares
-1,800
Change %
-53%
Price
$273.30
Shares after
1,610
Date
23 Jun 2026
Ownership
Direct
Footnotes
F6, F7, F8
ONC transaction

American Depositary Shares

Sale

Transaction value
$353,613
Shares
-1,290
Change %
-80%
Price
$274.12
Shares after
320
Date
23 Jun 2026
Ownership
Direct
Footnotes
F6, F7, F9
ONC transaction

American Depositary Shares

Sale

Transaction value
$88,030
Shares
-320
Change %
-100%
Price
$275.10
Shares after
0
Date
23 Jun 2026
Ownership
Direct
Footnotes
F6, F7, F10
ONC holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
5,605,310
Date
23 Jun 2026
Ownership
Direct
ONC holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
481,533
Date
23 Jun 2026
Ownership
See Footnote
Footnotes
F1
ONC holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
7,699,158
Date
23 Jun 2026
Ownership
See Footnote
Footnotes
F2
ONC holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
28,204,115
Date
23 Jun 2026
Ownership
See Footnote
Footnotes
F3
ONC holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
9,545,000
Date
23 Jun 2026
Ownership
See Footnote
Footnotes
F4
ONC holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
102,188
Date
23 Jun 2026
Ownership
See Footnote
Footnotes
F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 10 footnotes

Footnote F1

These securities are held by the P&O Trust, the beneficiaries of which include the Reporting Person's child and others, for which the Reporting Person disclaims beneficial ownership.

Footnote F2

These securities are held in a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership.

Footnote F3

These securities are held by Oyler Investment LLC, of which 99% of the limited liability company interests owned by a grantor retain annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership.

Footnote F4

These securities are held for the benefit of the Reporting Person in a Roth IRA PENSCO trust account.

Footnote F5

These securities are held by The John Oyler Legacy Trust for the benefit of the Reporting Person's child, for which the Reporting Person disclaims beneficial ownership.

Footnote F6

Each American Depositary Share represents 13 Ordinary Shares.

Footnote F7

The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 22, 2022, subject to continued service. Unvested securities are subject to accelerated vesting upon change of control or certain termination events.

Footnote F8

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $272.655 to $273.62, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Footnote F9

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $273.74 to $274.68, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Footnote F10

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $274.93 to $275.21, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .